<!DOCTYPE html>
<html>
  <head>
    <title>EUCRISA WV Sell Sheet</title>
    <link href="./resources/css/styles.css" type="text/css" rel="stylesheet"/>
  </head>
  <body>
    <div class="letter-page">
      <header>
        <img class="logo" src="resources/images/Pfizer_Eucrisa_Logo_Pos_RGB.png"/>
        <div class="header-text">
          Consider EUCRISA for your <br/>mild-to-moderate atopic dermatitis <br/>patients 2 years of age and older
        </div>
      </header>

<!-- Purple Box -->

      <div class="purple-box">
        <div class="purple-content">
          <div class="purple-text">
            <h1>Now, patients with Rx coverage through West Virginia Medicaid have formulary access to EUCRISA for $0.</h1>
            <p>Patients with prior authorization may be approved for 6 months of treatment with EUCRISA if they meet the following criteria:</p>
            <ul>
              <li><span>Diagnosed with atopic dermatitis</span></li>
              <li><span>2 years of age or older</span></li>
              <li><span>Documented 6-week trial and failure of at least 1 preferred medium-to-high potency corticosteroid* OR the topical calcineurin inhibitor Elidel* (pimecrolimus)</span></li>
            </ul>
            <div class="table-row header">
              <div class="left-align">West Virginia Medicaid plans include:</div>
              <div class="centered-text">Medicaid Pharmacy Lives</div>
            </div>

<!-- Plans Table -->

            <div class="table-row white">
              <div class="left-align">Anthem / UniCare (WV) - Medicaid</div>
              <div class="centered-text">130,000</div>
            </div>
            <div class="table-row white">
              <div class="left-align">WV Medicaid - Fee for Service</div>
              <div class="centered-text">128,000</div>
            </div>
            <div class="table-row white">
              <div class="left-align">Aetna Better Health (WV) - Medicaid</div>
              <div class="centered-text">118,000</div>
            </div>
            <div class="table-row white">
              <div class="left-align">The Health Plan (WV) - Medicaid</div>
              <div class="centered-text">73,000</div>
            </div>
            <div class="table-row white">
              <div class="left-align">Highmark BCBS / West Virginia Family Health - Medicaid</div>
              <div class="centered-text">61,000</div>
            </div>

            <p class="small">Not a guarantee of coverage and subject to change. Patients can learn more about their coverage by contacting eucrisa•4•you, their employer, health plan, pharmacy benefits manager (PBM), or retail pharmacy.</p>
            <p class="small">Data on file. Pfizer Inc, New York, NY.</p>
            <p class="small">*See the universal preferred drug list for a list of preferred agents.</p>

          </div>
        </div>
      </div>

<!-- ISI -->

      <div class="isi-text">
        <h3>Indication</h3>
        <p class="isi">EUCRISA is indicated for topical treatment of mild-to-moderate atopic dermatitis in patients 2 years of age and older.</p>
        <h3>Important Safety Information</h3>
        <h4>Contraindications</h4>
        <p class="isi">EUCRISA is contraindicated in patients with known hypersensitivity to crisaborole or any component of the formulation.</p>
        <h4>Warnings and Precautions</h4>
        <p class="isi">Hypersensitivity reactions, including contact urticaria, have occurred in patients treated with EUCRISA and should be suspected in the event of severe pruritus, swelling and erythema at the application site or at a distant site. Discontinue EUCRISA immediately and initiate appropriate therapy if signs and symptoms of hypersensitivity occur.</p>
        <h4>Adverse Reactions</h4>
        <p class="isi">The most common adverse reaction occurring in ≥1% of subjects in clinical trials was application site pain, such as burning or stinging.</p>
        <p class="prescribing-information">Please see accompanying Full Prescribing Information.</p>
      </div>

      <footer>
        <div class="endmatter">
          <span>PP-CRI-USA-0962</span>
          <span>© 2018 Pfizer Inc.</span>
          <span>All rights reserved</span>
          <span>January 2018</span>
        </div>
        <img src="resources/images/Pfizer_logo_4c.png" alt="Pfizer Logo"/>
      </footer>

    </div>
  </body>
</html>
